Monday, November 9, 2026 Never miss a recall or a rule change Get the free brief →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
Business & M&ACytrellis Brings ellacor into UM Nurse Practitioner CoursetodayRegulatoryFDA clears AMIRO LED wrinkle mask under 510(k)6 days agoBusiness & M&AGalderma lifts 2026 sales outlook to 22.5-23.5%todayBusiness & M&AGalderma nine-month sales hit $4.77B, guidance raised5 days agoMarketAllergan posts nine ASDS abstracts, two on GLP-1 patientsyesterdayBusiness & M&ASofwave names Optimedic main distributor in Spain5 days agoBusiness & M&AEvolus posts Q3 loss of $0.09, revenue tops estimatesyesterdayBusiness & M&AEvolus Q3 revenue up 13%, fourth straight positive EBITDA quarter4 days agoRegulatoryJudge bars Medicare price for Botox over plasma rule2 days agoBusiness & M&ASofwave Q3 revenue up 35% to $28.5M; China nod4 days agoBusiness & M&AHugel Signs Half of Target U.S. Accounts Post-Switch2 days agoBusiness & M&AMaple Grove med spa adds PA-led hormone and weight program3 days ago
Compliance · Live FDA data

Aesthetic Safety Signals

Adverse-event report counts for the injectables, fillers, and devices you use — pulled from the FDA's FAERS (drugs) and MAUDE (devices) databases. 380,169 reports tracked across 15 products.

Read these carefully — they are signals, not verdicts. An adverse-event report does not prove the product caused the event. Counts are not adjusted for how widely a product is used, anyone can file a report, and totals reflect all reported history. Use this to know what to watch and ask about — not to rank products.
Neurotoxin

Botox

FAERS
78,038reports
20%serious
Most-reported reactions
Drug Ineffective 26,747
Off Label Use 11,678
Therapeutic Response Decreased 4,512
Headache 4,150
Product Preparation Error 3,646

Dysport

FAERS
6,992reports
30%serious
Most-reported reactions
Off Label Use 2,523
Drug Ineffective 1,819
Product Preparation Error 757
Headache 479
Muscular Weakness 388

Xeomin

FAERS
5,811reports
13%serious
Most-reported reactions
Drug Ineffective 1,876
Off Label Use 1,218
Therapeutic Response Decreased 761
Injection Site Pain 343
Overdose 237

Jeuveau

FAERS
3,779reports
2%serious
Most-reported reactions
Drug Ineffective 1,590
Off Label Use 1,315
Therapeutic Product Effect Decreased 715
Drug Effect Less Than Expected 469
Headache 171

Daxxify

FAERS
75reports
32%serious
Most-reported reactions
Rash Papular 19
Drug Ineffective 13
Headache 8
Eyelid Ptosis 6
Anxiety 4
Dermal filler

Juvederm

MAUDE
10,024reports
88%serious

Sculptra

MAUDE
2,038reports
53%serious

Radiesse

MAUDE
1,678reports
76%serious

Restylane

MAUDE
1,242reports
80%serious
Energy device

CoolSculpting

MAUDE
11,288reports
98%serious

Morpheus8

MAUDE
65reports
100%serious

Ultherapy

MAUDE
42reports
93%serious

Emsculpt

MAUDE
6reports
83%serious
GLP-1 (weight-loss demand driver)

Tirzepatide (Mounjaro/Zepbound)

FAERS
181,068reports
18%serious
Most-reported reactions
Incorrect Dose Administered 32,155
Nausea 19,738
Injection Site Pain 14,616
Diarrhoea 11,312
Extra Dose Administered 10,288

Semaglutide (Wegovy/Ozempic)

FAERS
78,023reports
50%serious
Most-reported reactions
Nausea 11,150
Off Label Use 7,890
Vomiting 7,332
Diarrhoea 6,833
Decreased Appetite 5,107

When a safety signal turns into a recall, know first.

We watch these databases continuously. Inside MedSpa Pro flags the moment a product you use spikes, gets a warning, or hits a recall — and what to do about it.

Get the free brief

Source: openFDA FAERS & MAUDE. General information only — not medical, safety, or regulatory advice. Inside MedSpa is a general, impersonal publication for medical-aesthetics business owners. It is not individualized business, financial, medical, or legal advice. Any market or company information is general in nature and not a recommendation.

Inside MedSpa · Free brief

By the time it's news, it's too late.

FDA decisions, recalls and the rules you operate under, drafted from the source documents and sent free by email.

Get the free brief The free Inside MedSpa brief · no card · unsubscribe anytime.
FDA, recalls and rule changes for practice owners Get the free brief →